ACONAclarion, Inc.

Nasdaq aclarion.com


$ 0.29 $ 0.01 (1.75 %)    

Tuesday, 25-Jun-2024 15:56:02 EDT
QQQ $ 480.18 $ 0.58 (0.12 %)
DIA $ 389.82 $ -0.29 (-0.07 %)
SPY $ 544.23 $ 0.64 (0.12 %)
TLT $ 93.21 $ -0.35 (-0.37 %)
GLD $ 212.43 $ -1.76 (-0.82 %)
$ 0.29
$ 0.29
$ 0.00 x 0
$ 0.00 x 0
$ 0.29 - $ 0.29
$ 0.27 - $ 16.64
4,053,586
na
1.58M
$ -5.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-25-2023 06-30-2023 10-Q
5 07-03-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 06-06-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aclarions-nociscan-solution-to-play-key-role-in-lifehab-trial-evaluating-the-diagnosis-and-treatment-of-chronic-low-back-pain

LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitat...

 on-april-8-aclarion-inc-received-notice-of-delisting-or-failure-to-satisfy-a-continued-listing-rule-or-standard-from-nasdaq

- SEC Filing

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 why-virtra-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket

Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expect...

 aclarion-has-received-a-notice-of-allowance-for-its-us-patent-application-18190723-titled-magnetic-resonance-spectroscopy-pulse-sequence-acquisition-and-processing-system-and-method-for-diagnosing-pain

Patent Center (uspto.gov)

 aclarion-has-received-a-decision-to-grant-european-patent-number-ep3928695-titled-magnetic-resonance-spectroscopy-pulse-sequence-acquisition-and-processing-system-and-method-for-diagnosing-pain

https://register.epo.org/application?number=EP21157092